Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study.
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.
Foundation Model for Predicting Prognosis and Adjuvant Therapy Benefit From Digital Pathology in GI Cancers.
Machine learning prediction for early-stage melanoma outcomes: recurrence-free survival, disease-specific survival, and overall survival.
Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort study.
